Principal Financial Group Inc. Acquires Shares of 128,573 Strata Critical Medical $SRTA

Principal Financial Group Inc. bought a new position in Strata Critical Medical (NASDAQ:SRTA) in the 1st quarter, Holdings Channel.com reports. The institutional investor bought 128,573 shares of the company’s stock, valued at approximately $537,000.

Separately, Granite Investment Partners LLC lifted its stake in shares of Strata Critical Medical by 77.0% in the first quarter. Granite Investment Partners LLC now owns 18,181 shares of the company’s stock worth $76,000 after buying an additional 7,911 shares in the last quarter. Institutional investors and hedge funds own 47.36% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded shares of Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, May 11th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, Strata Critical Medical currently has an average rating of “Moderate Buy” and a consensus target price of $8.00.

Insiders Place Their Bets

In other Strata Critical Medical news, CAO Amir Cohen sold 40,575 shares of the company’s stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $5.91, for a total transaction of $239,798.25. Following the transaction, the chief accounting officer owned 151,263 shares in the company, valued at approximately $893,964.33. This represents a 21.15% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Melissa M. Tomkiel sold 29,730 shares of the company’s stock in a transaction dated Monday, June 8th. The shares were sold at an average price of $5.87, for a total transaction of $174,515.10. Following the transaction, the chief executive officer owned 1,892,774 shares in the company, valued at $11,110,583.38. This represents a 1.55% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders sold 116,931 shares of company stock valued at $687,184. 15.50% of the stock is owned by insiders.

Strata Critical Medical Stock Down 1.4%

SRTA stock opened at $5.02 on Friday. Strata Critical Medical has a 1-year low of $3.67 and a 1-year high of $6.50. The business has a fifty day simple moving average of $5.52. The stock has a market capitalization of $434.38 million, a PE ratio of -62.75 and a beta of 2.22.

Strata Critical Medical (NASDAQ:SRTA) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.03 EPS for the quarter, beating the consensus estimate of ($0.04) by $0.07. Strata Critical Medical had a negative return on equity of 4.06% and a net margin of 20.56%.The company had revenue of $67.38 million for the quarter. Analysts expect that Strata Critical Medical will post -0.14 EPS for the current year.

Strata Critical Medical Company Profile

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.